Stockscreener 앱 받기
2.96
1.99%
-0.06
시간 외 거래:
2.98
0.02
+0.68%
전일 마감가:
$3.02
열려 있는:
$3.02
하루 거래량:
5.95M
Relative Volume:
1.32
시가총액:
$784.83M
수익:
$194.75M
순이익/손실:
$-51.26M
주가수익비율:
-10.57
EPS:
-0.28
순현금흐름:
$-23.38M
1주 성능:
-5.73%
1개월 성능:
-20.43%
6개월 성능:
+59.57%
1년 성능:
+114.49%
1일 변동 폭
$2.90
$3.0499
1주일 범위
$2.90
$3.22
52주 변동 폭
$1.24
$4.0787
Akebia Therapeutics Inc Stock (AKBA) Company Profile
명칭
Akebia Therapeutics Inc
전화
617-871-2098
주소
245 FIRST STREET, CAMBRIDGE, MA
AKBA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AKBA
Akebia Therapeutics Inc
|
2.96 | 800.74M | 194.75M | -51.26M | -23.38M | -0.28 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Akebia Therapeutics Inc Stock (AKBA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-04 | 재개 | H.C. Wainwright | Buy |
| 2025-04-28 | 개시 | Leerink Partners | Outperform |
| 2025-04-01 | 개시 | Jefferies | Buy |
| 2023-11-29 | 재개 | BTIG Research | Buy |
| 2023-08-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-05-31 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-03-31 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-03-31 | 다운그레이드 | Needham | Buy → Hold |
| 2022-03-31 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-03-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-29 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-11-14 | 재확인 | Needham | Buy |
| 2019-08-06 | 재확인 | H.C. Wainwright | Buy |
| 2019-07-11 | 재확인 | H.C. Wainwright | Buy |
| 2019-05-02 | 개시 | JP Morgan | Overweight |
| 2019-03-20 | 개시 | Citigroup | Neutral |
| 2018-09-07 | 재개 | Morgan Stanley | Equal-Weight |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-06-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-12-19 | 개시 | Piper Jaffray | Overweight |
| 2017-12-07 | 개시 | BTIG Research | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Sector Perform |
| 2017-07-10 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-27 | 재확인 | H.C. Wainwright | Buy |
| 2017-04-27 | 재확인 | Needham | Buy |
| 2016-12-27 | 재확인 | H.C. Wainwright | Buy |
| 2016-12-20 | 재확인 | JMP Securities | Mkt Outperform |
| 2016-11-15 | 개시 | Aegis Capital | Buy |
| 2016-09-29 | 개시 | Brean Capital | Buy |
| 2016-03-16 | 재확인 | Needham | Buy |
| 2016-01-21 | 개시 | Credit Suisse | Neutral |
모두보기
Akebia Therapeutics Inc 주식(AKBA)의 최신 뉴스
Akebia Therapeutics, Inc. (NASDAQ:AKBA) most popular amongst individual investors who own 55% of the shares, institutions hold 43% - Yahoo Finance
What are Akebia Therapeutics Inc.’s earnings expectations2025 Growth vs Value & Entry Point Confirmation Alerts - خودرو بانک
How to interpret RSI for Akebia Therapeutics Inc. stockPortfolio Return Report & AI Enhanced Execution Alerts - Newser
Panic Selling: Is Akebia Therapeutics Inc. forming a bullish divergencePortfolio Gains Summary & Daily Stock Trend Watchlist - خودرو بانک
Can Akebia Therapeutics Inc. keep up with sector leadersTrade Analysis Summary & Scalable Portfolio Growth Methods - خودرو بانک
Is Akebia Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Detecting support and resistance levels for Akebia Therapeutics Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Measuring Akebia Therapeutics Inc.’s beta against major indicesPortfolio Performance Summary & High Accuracy Buy Signal Tips - Newser
Does Akebia Therapeutics Inc. have pricing powerDividend Hike & High Accuracy Trade Alerts - 강소기업뉴스
Akebia Therapeutics' Strategic Position in the Renal Therapeutics Market - AInvest
Transcript : Akebia Therapeutics, Inc. Presents at Wells Fargo 20th Annual Healthcare Conference 2025, Sep-04-2025 08 - MarketScreener
Strategies to average down on Akebia Therapeutics Inc.2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
Akebia at Wells Fargo Conference: Strategic Growth in Healthcare - Investing.com
What is Akebia Therapeutics Inc. s 5 year growth outlookJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
Is Akebia Therapeutics Inc. forming a bottoming basePortfolio Growth Summary & Long-Term Investment Growth Plans - Newser
Is Akebia Therapeutics Inc. stock heavily shortedJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
News impact scoring models applied to Akebia Therapeutics Inc.July 2025 Action & Fast Exit and Entry Strategy Plans - Newser
What Fibonacci levels say about Akebia Therapeutics Inc. reboundPortfolio Growth Summary & Real-Time Chart Pattern Alerts - Newser
What’s the recovery path for long term holders of Akebia Therapeutics Inc.Chart Signals & High Win Rate Trade Tips - Newser
Will Akebia Therapeutics Inc. outperform the marketJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Using Python tools to backtest Akebia Therapeutics Inc. strategiesBond Market & Real-Time Stock Entry Alerts - Newser
Regression analysis insights on Akebia Therapeutics Inc. performanceTrade Analysis Report & Long-Term Safe Investment Plans - Newser
Understanding Akebia Therapeutics Inc.’s price movementRecession Risk & High Return Stock Watch Alerts - Newser
Akebia Therapeutics reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Akebia Therapeutics shares rise 1.93% after-hours following inducement grants to new employees. - AInvest
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Stock Report: Can Akebia Therapeutics Inc. stock outperform in a bear market2025 Earnings Surprises & Accurate Buy Signal Notifications - خودرو بانک
Does Akebia Therapeutics Inc. have declining or rising EPSJuly 2025 Price Swings & Verified Momentum Stock Ideas - خودرو بانک
Analyzing drawdowns of Akebia Therapeutics Inc. with statistical toolsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - Newser
Can Akebia Therapeutics Inc. stock outperform in a bear marketMarket Growth Review & High Win Rate Trade Tips - خودرو بانک
Akebia Therapeutics Inc. Stock Recovery Path — Analyst Breakdown2025 Momentum Check & Stock Market Timing Techniques - beatles.ru
Is Akebia Therapeutics Inc. reversing from oversold territoryJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
How moving averages guide Akebia Therapeutics Inc. tradingMarket Trend Summary & Reliable Momentum Entry Alerts - Newser
Visual trend scoring systems applied to Akebia Therapeutics Inc.Market Trend Review & Free Reliable Trade Execution Plans - Newser
Using Bollinger Bands to evaluate Akebia Therapeutics Inc.2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Using Ichimoku Cloud for Akebia Therapeutics Inc. technicalsMarket Activity Report & Weekly Chart Analysis and Guides - Newser
Why Akebia Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Breakouts & High Conviction Trade Alerts - Newser
Elliott Wave Theory Predicts Pullback in Akebia Therapeutics Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Sentiment analysis tools applied to Akebia Therapeutics Inc.Market Growth Summary & AI Driven Stock Price Forecasts - Newser
Akebia Therapeutics Inc (AKBA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.53%
자본화:
|
볼륨(24시간):